Suchergebnisse - "Bowden, Thomas A"

PubPharm (18)

1

Central tolerance shapes the neutralizing B cell repertoire against a persisting virus in its natural host

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2024

von Florova, M. | Abreu-Mota, T. | Paesen, G. | +14

2

Safety and immunogenicity of a ChAdOx1 vaccine against Rift Valley fever in UK adults : an open-label, non-randomised, first-in-human phase 1 clinical trial

enthalten in: The Lancet. Infectious diseases | 2023

von Jenkin, D. | Wright, D. | Folegatti, P. | +16

CommentIn: Lancet Infect Dis. 2023 Aug;23(8):887-889. - PMID 37060918

3

Structure of trimeric pre-fusion rabies virus glycoprotein in complex with two protective antibodies

enthalten in: Cell host & microbe | 2022

von Ng, W. | Fedosyuk, S. | English, S. | +7

4

Structural Basis for a Neutralizing Antibody Response Elicited by a Recombinant Hantaan Virus Gn Immunogen

enthalten in: mBio | 2021

von Rissanen, I. | Krumm, S. | Stass, R. | +10

5

Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant

enthalten in: Immunity | 2021

von Graham, C. | Seow, J. | Huettner, I. | +26

UpdateOf: bioRxiv. 2021 Feb 03;:. - PMID 33564766

6

Antibody evasion by the P.1 strain of SARS-CoV-2

enthalten in: Cell | 2021

von Dejnirattisai, W. | Zhou, D. | Supasa, P. | +47

7

Overcoming Symmetry Mismatch in Vaccine Nanoassembly through Spontaneous Amidation

enthalten in: Angewandte Chemie (International ed. in English) | 2021

von Rahikainen, R. | Rijal, P. | Tan, T. | +7

8

Case Study : Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer

enthalten in: Cell | 2020

von Avanzato, V. | Matson, M. | Seifert, S. | +11

9

Molecular rationale for antibody-mediated targeting of the hantavirus fusion glycoprotein

enthalten in: eLife | 2020

von Rissanen, I. | Stass, R. | Krumm, S. | +11

10

A Protective Monoclonal Antibody Targets a Site of Vulnerability on the Surface of Rift Valley Fever Virus

enthalten in: Cell reports | 2018

von Allen, E. | Krumm, S. | Raghwani, J. | +16